A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)
Clinical trial NCT03773393 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03773393
- Sponsor
- Cellenkos, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2027-05-25
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.